Search clinical trials for: Semaglutide (administered by DV3396 pen)

Total 188 results

Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Novo Nordisk A/S

Terminated

A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

Obesity | Overweight

Germany
Novo Nordisk A/S

Completed

A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens

Obesity | Overweight

Germany
Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Novo Nordisk A/S

Completed

A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Novo Nordisk A/S

Completed

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

Diabetes Mellitus, Type 2

Germany
Woman's
Novo Nordisk A/S

Recruiting

Treatment to Regress to Normoglycemia in Women With a Recent History of GDM (SWEET)

Pre Diabetes | Postpartum Disorder

United States
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD06 DNA Plasmid for HCC After Radical Resection

Hepatocellular Carcinoma

China
University of Pennsylvania

Recruiting

Feasibility of Semaglutide in Advanced Lung Disease

Obesity | Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis, Pulmonary

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)

Diabetes Mellitus, Type 1

United States
Universitaire Ziekenhuizen KU Leuven
Jessa Hospital; Universitair Ziekenhuis Brussel; University Hospital, Antwerp; AZ... and other collaborators

Recruiting

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes (SERENA)

Glucose Intolerance After a Recent History of Gestational Diabetes

Belgium
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma

Multiple Myeloma

Belgium, France, Germany
Sunovion Respiratory Development Inc.

Completed

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Type 2 Diabetes

China
University of Erlangen-Nürnberg Medical School

Recruiting

Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes (SEMA)

Diabetes Mellitus, Type 2

Germany
State University of New York at Buffalo
National Center for Advancing Translational Sciences (NCATS)

Active, not recruiting

Semaglutide Use in Elderly Obese Patients

Obesity | Aging

United States
PowderMed

Completed

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

HSV-2

United States
PowderMed

Completed

Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection

Chronic Hepatitis B

Thailand, Hong Kong, Singapore, Taiwan
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

High-grade Squamous Intraepithelial Lesion (HSIL)

China
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Type 2 Diabetes Mellitus | Obesity, Childhood | Impaired Glucose Tolerance | Non-Alcoholic Fatty Liver Disease

United States
Beth Israel Deaconess Medical Center

Completed

Efficacy of Transversus Abdominis Plane (TAP) Block Techniques: Surgeon vs Anesthesia - Ultrasound Guidance

Post Operative Analgesia | Non-inferiority Trial

United States
The Hospital for Sick Children

Unknown

Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration

Meconium Aspiration Syndrome

Canada
Eli Lilly and Company

Completed

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Diabetes Mellitus, Type 2

United States
Air Force Military Medical University, China

Unknown

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

Cervical Cancer

China
Canadian Medical and Surgical Knowledge Translation...
Unity Health Toronto; Western University, Canada

Recruiting

Semaglutide and Vascular Regeneration (SEMA-VR)

Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Atherosclerosis

Canada
Aga Khan University
Rehman Medical Institute - RMI

Recruiting

"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."

Diabetes Mellitus, Type 2 | Weight Change, Body

Pakistan
University of Maryland, Baltimore

Recruiting

Pharmacogenetics of Response to GLP1R Agonists (PORT)

Obesity | Diabetes Type 2

United States
Prometheus Biosciences, Inc., a subsidiary of Merck...

Active, not recruiting

A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease (APOLLO-CD)

Crohn Disease

United States, Australia, Belgium, Canada, Czechia, France, Georgia, Poland
PowderMed

Completed

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

HSV-2

United States
Vanderbilt University Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) (GATA-3)

Asthma

United States
Children's Hospital Medical Center, Cincinnati
National Heart, Lung, and Blood Institute (NHLBI); University of South Florida

Recruiting

Safety and Efficacy of PMT Therapy of hPAP

Hereditary Pulmonary Alveolar Proteinosis

United States
Genexine, Inc.

Unknown

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation (GX-188E)

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
University of Nottingham
Medical Research Council

Recruiting

Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets (SemVLCD)

Type 2 Diabetes Mellitus in Obese

United Kingdom
Second Xiangya Hospital of Central South University

Recruiting

Subcutaneous Semaglutide in Systemic Scleroderma

Fibrosis | Scleroderma, Systemic | Semaglutide

China
Geisinger Clinic

Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy (RAISE-KT)

Obesity | Diabetic Kidney Disease | Type 2 Diabetes Mellitus in Obese | CKD | Severe Obesity

United States
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
University of Colorado, Denver
Novo Nordisk A/S

Recruiting

Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) (SIB)

Type 2 Diabetes | Chronic Inflammation | Intestinal Permeability

United States
Genexine, Inc.

Unknown

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
Genexine, Inc.

Completed

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3 (CIN3)

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
The Deutsche Diabetes Forschungsgesellschaft e.V.
Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaborators

Recruiting

Combined Active Treatment in Type 2 Diabetes With NASH (COMBAT_T2_NASH)

Type 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)

Germany, Austria
Virginia Commonwealth University
Novo Nordisk A/S

Recruiting

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD

United States
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
University of Hull

Not yet recruiting

Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

United Kingdom
University of California, Los Angeles

Recruiting

Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.

Obesity

United States
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Cystic Fibrosis

Czechia, Moldova, Republic of, Slovakia
University of California, Los Angeles
Centers for Medicare and Medicaid Services

Completed

Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)

Dementia

United States
Fondation Ophtalmologique Adolphe de Rothschild

Withdrawn

Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real Life (NEPALE)

HIV+ Patients
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults

Zika Virus

United States

Search clinical trials for: Semaglutide (administered by DV3396 pen)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations